Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Conventional Toothpaste

Phase 3

LLoma Linda University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Gingival InflammationNot yet recruiting

Gingival InflammationPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q4 2026

Phase 3Not yet recruiting

Gingival Inflammation

NCT07124533

Clinical

Trials by Indication[1]

Gingival Inflammation1 trial

Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences: A 6-week Randomized Controlled Trial

Not yet recruiting·LLoma Linda University·Phase 3·NCT07124533·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Conventional Toothpaste. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Conventional Toothpaste. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Loma Linda University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: LLoma Linda University

Related News